STOCK TITAN

3,878-Share Rule 144 Notice for DGX (NYSE: DGX) Insider Sales

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

DGX files a Rule 144 notice to sell 3,878 common shares tied to restricted stock vesting on 02/23/2026.

The filing also reports recent sales by Michael Prevoznik of 1,111 shares on 02/19/2026 for $227,566.13 and 526 shares on 03/03/2026 for $109,265.98.

Positive

  • None.

Negative

  • None.

Insights

Rule 144 notice lists a small resale tied to recent vesting and two recent disposals.

The filing states 3,878 common shares are to be sold following a restricted stock vesting event on 02/23/2026. It also discloses two recent sales by Michael Prevoznik: 1,111 shares on 02/19/2026 for $227,566.13 and 526 shares on 03/03/2026 for $109,265.98.

Cash‑flow treatment and purchaser details are not included in the excerpt; subsequent filings would state execution details. The actions shown are routine compliance disclosures for resale under Rule 144.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the DGX Rule 144 filing disclose?

It discloses a notice to sell 3,878 common shares tied to restricted stock vesting on 02/23/2026. It also lists two recent sales by Michael Prevoznik totaling 1,637 shares with aggregate proceeds shown.

Who reported recent sales in the DGX filing?

The filing lists sales by Michael Prevoznik, including 1,111 shares sold on 02/19/2026 and 526 shares sold on 03/03/2026, with reported proceeds for each transaction.

What price proceeds are reported for the insider sales in DGX?

Proceeds shown are $227,566.13 for 1,111 shares on 02/19/2026 and $109,265.98 for 526 shares on 03/03/2026, as stated in the filing.

Are the 3,878 shares in the DGX filing newly vested shares?

Yes; the excerpt ties the 3,878 common shares to a restricted stock vesting event on 02/23/2026, as indicated in the securities-to-be-sold section.

Does the DGX filing state who will receive sale proceeds?

The excerpt does not state proceeds recipients explicitly; the securities-to-be-sold line attributes the shares to Issuer under Compensation, but detailed cash-flow treatment is not provided in the excerpt.
Quest Diagnostics Inc

NYSE:DGX

DGX Rankings

DGX Latest News

DGX Latest SEC Filings

DGX Stock Data

22.41B
109.04M
Diagnostics & Research
Services-medical Laboratories
Link
United States
SECAUCUS